For the Inventor, By the Inventor

Enter assignee name

Pasadena, CA, United States of America

Autoimmune Inc.

USPTO Granted Patents = 32

CIPO Patents = 3

Trademarks = 1

Forward Citations = 997

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Howard L Weiner (31 out of 46 patents)

David A Hafler (22 out of 25 patents)

Zhengyi Zhang (6 out of 6 patents)

4. David Allen Hafler (6 out of 6 patents)

5. David E Trentham (5 out of 5 patents)

6. Ahmad Al-Sabbagh (4 out of 4 patents)

7. Ariel Miller (3 out of 4 patents)

8. George S Eisenbarth (3 out of 8 patents)

9. Mohamed Sayegh (3 out of 3 patents)

10. Charles B Carpenter (3 out of 4 patents)

11. Zhengi Zhang (3 out of 3 patents)

12. George Eisenberth (2 out of 2 patents)

13. Dale P DeVore (1 out of 36 patents)

14. Robert B Nussenblatt (1 out of 3 patents)

15. Alan G Palestine (1 out of 2 patents)

32 patents: Sort by Forward Citations

1. 6703361 - Method of treating or preventing Type 1 diabetes by oral administration of insulin (2004-03-09),

2. 6645504 - Bystander suppression of type I diabetes by oral administration of glucagon (2003-11-11),

3. 6077509 - Peptide fragments of myelin basic protein (2000-06-20),

4. 6039947 - Peptides derived from immunodominant epitopes of myelin basic protein (2000-03-21),

5. 6036957 - Suppression of T-cell proliferation using peptide fragments of myelin (2000-03-14),

6. 6019971 - Treatment of autoimmune arthritis by oral administration of collagen (2000-02-01),

7. 5961977 - Method of treating or preventing autoimmune uveoretinitis in mammals (1999-10-05),

8. 5935577 - Treatment of autoimmune disease using tolerization in combination with (1999-08-10),

9. 5869093 - Treatment of immune diseases by oral administration of autoantigens (1999-02-09),

10. 5869054 - Treatment of multiple sclerosis by oral administration of autoantigens (1999-02-09),

11. 5858980 - Peptide fragments of myelin basic protein (1999-01-12),

12. 5858968 - Method of treating or preventing type 1 diabetes by oral administration (1999-01-12),

13. 5858364 - Pharmaceutical dosage form for treatment of multiple sclerosis (1999-01-12),

14. 5856446 - Method of treating rheumatoid arthritis with low dose type II collagen (1999-01-05),

15. 5849298 - Treatment of multiple sclerosis by oral administration of bovine myelin (1998-12-15),

Autoimmune Inc. is a biopharmaceutical company dedicated to developing innovative therapies for autoimmune diseases. Our mission is to improve the lives of patients by delivering effective and safe treatments. We specialize in the research, development, and commercialization of novel drugs that target and modulate the immune system. With a strong focus on precision medicine, we aim to provide personalized therapies that address the specific needs of each patient. Through our cutting-edge research and collaborative efforts, we strive to make a significant impact in the field of autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

32 Patents

#19 in Pasadena, CA

#2,459 in California

#10,247 in US

#20,095 in the World

Pasadena, CA, United States of America

Autoimmune Inc.

Forward Citations = 997

17 inventors:

Howard L Weiner (31 out of 46 patents)

David A Hafler (22 out of 25 patents)

Zhengyi Zhang (6 out of 6 patents)

4. David Allen Hafler (6 out of 6 patents)

5. David E Trentham (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…